The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
WW announced on Thursday that it will be laying off employees and cutting costs to the tune of $100 million per year.
Though small compared to each company’s total workforces, work stoppages have set uncomfortable precedents for management.
This month marks the end of what Goldman Sachs estimates will be a record year for stock buybacks, with a volume of roughly $930 billion.
In the first 11 months of the year, 1,991 CEOs have announced their departures, up 16% compared to the same timeframe last year.